The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Frontier Smart Technologies Grp Ltd

14 Jun 2019 11:40

RNS Number : 3446C
Science Group PLC
14 June 2019
 

 

14 June 2019

 

Science Group plc

 

Investment in Frontier Smart Technologies Group Limited

("Frontier")

 

 

 

Science Group plc (Science Group") notes the announcement by Frontier on 14 June 2019 (the "Frontier Announcement") of a preliminary approach from another party in relation to a corporate transaction. In contrast to the announcement made by Frontier on 20 May 2019 disclosing Science Group's interest, the Frontier Announcement this morning does not identify the potential bidder or provide details of the proposed price. Science Group also notes that the Frontier Announcement this morning also does not provide detail on conditionality or structure.

 

However, Frontier does notify shareholders that the approach is at a preliminary stage and that there can be no certainty that the approach will result in a formal offer for Frontier, nor as to the terms of any such offer if made. Furthermore, Frontier highlights that it is urgently seeking to clarify deliverability of this second approach, a very significant point in the opinion of Science Group.

 

With regard to deliverability, Science Group is currently the largest shareholder of Frontier, holding approximately 28.3% of the voting share capital. Science Group does not intend to sell its shares to any other potential bidder or vote in favour of any alternative transaction, including any vote on the disposal of assets of Frontier. In particular, Science Group notes that it will not be possible for another bidder to implement the transaction as a statutory merger or scheme of arrangement without the cooperation of Science Group, since each of these transactions would require the approval of at least 75% of Frontier shareholders voting.

 

Science Group also notes that, whilst another bidder could potentially gain voting control of Frontier by making a contractual offer, any subsequent delisting from AIM would also require the approval of at least 75% of Frontier shareholders voting, therefore also requiring Science Group cooperation. If de-listing did not occur, the integration of Frontier into another business with at least one substantial minority shareholder would, in Science Group's opinion, be likely to be challenging and would be subject to material legal and operational constraints.

 

Science Group also highlights the potential risks to Frontier of a protracted process, taking into account the financial position of Frontier as reported in the trading update on 9 May 2019. In that announcement, Frontier forecast an EBITDA trading loss of $2.2 million in the first half of 2019 and net debt at 30 April 2019 of $3.9 million. Frontier's bank facility is £5 million, approximately $6 million, although the Frontier announcement on 9 May did not provide any detail as to the headroom relative to the bank covenants, despite the reported challenging trading environment and deteriorating cash position.

 

As a result, Science Group reiterates the uncertainty regarding the deliverability of the second approach, as well as the potential risks to Frontier from further delay. Therefore, Science Group again encourages the board of directors of Frontier to engage with Science Group to complete a transaction with Science Group in a timely manner.

 

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

Panmure Gordon (UK) Limited

Dominic Morley / Alina Vaskina (Nominated Adviser)

Erik Anderson (Corporate Broking)

 

 

Tel: +44 (0) 20 7886 2500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBGGDLCXBBGCS
Date   Source Headline
20th Feb 201210:16 amRNSHolding(s) in Company
16th Feb 20127:00 amRNSCompletion of placing
13th Feb 20127:00 amRNSTrading update
13th Feb 20127:00 amRNSPlacing raises £11.2m
3rd Jan 20127:00 amRNSSubsidiary established with Imagination Technologi
24th Oct 20117:00 amRNSTelran distribution clearance
21st Sep 20117:00 amRNSHalf year results
9th Aug 20114:52 pmRNSNotice of Results
29th Jul 20117:00 amRNSHalf year trading update
11th Jul 20117:00 amRNSFDA approval for Sensium
11th Jul 20117:00 amRNSJV established with CCE
5th May 20115:24 pmRNSResult of AGM
29th Mar 20117:00 amRNSFull year results
16th Mar 20113:16 pmRNSNotice of Results
16th Mar 20113:05 pmRNSHolding(s) in Company
3rd Mar 20114:34 pmRNSIssue of Equity
2nd Mar 20118:14 amRNS£1.8m Raised
10th Feb 20117:41 amRNSStrategic Investment
1st Feb 20117:00 amRNSTELRAN Launch
1st Feb 20117:00 amRNSYear End Trading Update
30th Nov 20107:00 amRNSXENIF processor in production
15th Sep 20107:00 amRNSInterim Results
24th Aug 20109:33 amRNSIssue of Equity
11th Aug 201011:52 amRNSNotice of Results
27th Jul 20107:00 amRNSLicense agreement
15th Jul 201010:19 amRNSIssue of Equity and Exercise of Options
30th Jun 20107:00 amRNSTrading Update
16th Jun 20108:49 amRNSAnnual Financial Report
26th May 20109:07 amRNSChange of Name
10th May 20102:52 pmRNSResult of AGM
30th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSQuanta takes strategic stake
11th Mar 20104:27 pmRNSDirector dealings
10th Mar 201011:26 amRNSNotice of Results
23rd Feb 20107:00 amRNSClinical Trial Update
1st Feb 20102:02 pmRNSExercise of Options - replacement
29th Jan 201012:33 pmRNSExercise of Options
22nd Dec 200911:19 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSHolding(s) in Company
17th Dec 20093:10 pmPRNResult of EGM
14th Dec 20093:34 pmPRNDirector/PDMR Shareholding
1st Dec 20097:00 amPRNProposed Placing and Update
9th Nov 20091:20 pmRNSNational Microelectronics Institute Award
2nd Nov 20097:00 amPRNSensium Digital Plaster European Trial
28th Sep 20097:00 amPRNHalf-yearly Report
22nd Sep 200912:16 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSCorrection re holding in company
10th Sep 20097:00 amRNSHolding(s) in Company
7th Aug 200912:01 pmRNSHolding(s) in Company
22nd Jul 200911:21 amPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.